News-June-04-2026

June 4, 2026 — Representative Sara Jacobs introduced the Sectoral AI Governance Act to authorize federal agencies to write rules for algorithmic decision-making systems when AI use is likely to materially contribute to violations of existing federal law, Representatives Jay Obernolte and Lori Trahan released a bipartisan discussion draft of the Great American AI Act to solicit feedback on a federal AI governance framework before formal introduction, AI executives, researchers, and policy experts urged lawmakers to mandate nucleic-acid synthesis screening and recordkeeping to reduce AI-enabled biological-weapons risk, and a federal court dismissed Elon Musk's claims against OpenAI and its executives after an advisory jury found that Musk waited too long to sue.

Contents

1. Jacobs introduces Sectoral AI Governance Act
2. Obernolte and Trahan release Great American AI Act draft
3. AI executives urge DNA synthesis screening legislation
4. Federal court dismisses Musk claims against OpenAI as time-barred

---

Jacobs introduces Sectoral AI Governance Act

Representative Sara Jacobs of California introduced the Sectoral AI Governance Act on June 3, 2026, describing it as legislation to give federal agencies a consistent framework for writing rules when AI or algorithmic decision-making systems are likely to materially contribute to violations of existing federal laws. The bill targets high-stakes uses of AI in areas including employment, lending, housing, health care, finance, consumer protection, education, and public services, and Jacobs's announcement said agencies already enforce laws in those domains but may lack a clear and coordinated basis for rulemaking when AI contributes to unlawful harms.

The proposal would require agencies to seek early public input through an advance notice of proposed rulemaking before proposing rules, preserve enforcement for violations of underlying federal law, and preserve state authority to regulate algorithmic decision-making systems unless state rules conflict with the Act or rules issued under it. Jacobs said the bill is meant to prevent existing federal rights from becoming ineffective when companies outsource decisions to algorithms.

---

Obernolte and Trahan release Great American AI Act draft

Representatives Jay Obernolte of California and Lori Trahan of Massachusetts released a June 4, 2026 discussion draft of the Great American AI Act, describing it as bipartisan legislation to create a federal framework for United States AI governance before a formal bill introduction. The lawmakers said the draft was released for stakeholder, expert, and public feedback, and the announcement listed Representatives Scott Franklin, Suhas Subramanyam, Erin Houchin, and Scott Peters as supporters joining the proposal's release.

The proposal is significant for AI-law tracking because Obernolte's announcement says the draft seeks a national framework for advanced AI systems while avoiding a patchwork of state laws, and Houchin's quoted statement says the bill would create a clear national standard while preserving state and parental authority to protect children. The announcement linked the discussion-draft text and a section-by-section summary, making the release a concrete federal legislative development rather than only a policy speech.

---

AI executives urge DNA synthesis screening legislation

A public letter from life-sciences researchers, technologists, and policy experts called for mandatory screening and recordkeeping for synthetic nucleic acids, arguing that customer and order screening should become a legal requirement for DNA-synthesis providers because AI systems can lower barriers to designing dangerous biological agents. The letter's signatories include OpenAI CEO Sam Altman, Anthropic CEO Dario Amodei, Google DeepMind CEO Demis Hassabis, and other AI, biotechnology, and policy figures, according to contemporaneous coverage of the letter.

The proposal asks Congress to require synthesis providers to screen orders and customers against hazards and risk indicators, maintain records, and support enforcement mechanisms, while the letter says voluntary industry practices are not enough for a risk that can scale across providers and jurisdictions. The development is legally significant because it frames AI-biosecurity safeguards as a federal statutory problem rather than only a model-lab safety policy issue.

---

Federal court dismisses Musk claims against OpenAI as time-barred

A federal court in Oakland dismissed Elon Musk's claims against OpenAI and its top executives on Monday after a nine-person advisory jury found that Musk missed the statutory deadline for filing the suit. Judge Yvonne Gonzalez Rogers accepted the advisory verdict as the court's own, and the jury reached its conclusion after a three-week trial and less than two hours of deliberation.

Musk, an OpenAI co-founder who invested $38 million in the organization's early years, had accused OpenAI CEO Sam Altman and other leaders of abandoning a nonprofit mission in favor of a profit-driven structure. OpenAI argued that the dispute was a business rivalry and that Musk filed the lawsuit to undercut OpenAI while supporting his competing AI company xAI. Musk said he would appeal and characterized the decision as resting on timing rather than the merits of his allegations.

The ruling is significant for AI governance litigation because it ends, at least at the trial-court level, Musk's bid to use charitable-trust and founding-mission theories to constrain OpenAI's corporate evolution. The trial also produced testimony from Musk, Altman, OpenAI president Greg Brockman, Microsoft CEO Satya Nadella, and others involved in OpenAI's transition from its early nonprofit structure to a major commercial AI developer.